INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY AND TIES-AND-UNITS-IN-THE-CLINICAL-LABORATORY-SCIENCES - VI - PROPERTIES AND UNITS IN IOC PROHIBITED DRUGS (IFCC-IUPAC RECOMMENDATIONS 1997)

Citation
H. Olesen et al., INTERNATIONAL-FEDERATION-OF-CLINICAL-CHEMISTRY AND TIES-AND-UNITS-IN-THE-CLINICAL-LABORATORY-SCIENCES - VI - PROPERTIES AND UNITS IN IOC PROHIBITED DRUGS (IFCC-IUPAC RECOMMENDATIONS 1997), Clinica chimica acta, 268(1-2), 1997, pp. 5-73
Citations number
17
Language
INGLESE
art.tipo
Article
Categorie Soggetti
Medical Laboratory Technology",Biology
Journal title
ISSN journal
0009-8981
Volume
268
Issue
1-2
Year of publication
1997
Pages
5 - 73
Database
ISI
SICI code
0009-8981(1997)268:1-2<5:IAT>2.0.ZU;2-2
Abstract
The term designating a substance being an active ingredient of a drug may be a generic name, a nonproprietary name, a registered trade name, a fantasy name or other. This causes difficulties in the transmission of request and report on such substances to and from the clinical lab oratories, and In the collating of this information from different sou rces. The document comprises a list of properties of drugs of abuse in biological fluids as defined by the international Olympic Committee M edical Code for use in electronic transmission systems. Standard syste matic names are presented with a code value for each. The coding schem es thus prepared are accessible on Internet from C-NPU Home page addre ss: http://inet.uni-c.dk/ similar to qukb7642 Published by Elsevier Sc ience B.V.